Navigation Links
New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo
Date:10/26/2007

Interim Results From Open-Label Follow-up Include Longer-term Safety

Findings

BOSTON, Oct. 26 /PRNewswire/ -- Adults with Attention Deficit Hyperactivity Disorder (ADHD) treated with CONCERTA(R) OROS(R) methylphenidate HCl Extended-release Tablets showed significant improvements in ADHD symptom management compared to adults taking placebo, according to study results presented today at a major psychiatric medical meeting.

"Pharmacological treatment of children and adolescents with ADHD is clearly established but relatively less is known about the treatment of adults with ADHD," notes the study's medical director, Sally Berry, M.D., PhD., of Johnson & Johnson Pharmaceutical Research and Development, LLC. "We're encouraged that the CONCERTA(R) findings presented today -- in which CONCERTA(R) significantly improved ADHD symptom management in adults -- can benefit the growing body of knowledge in this important therapeutic area." The data presented today are part of a Supplemental New Drug Application (sNDA) submitted in August 2007 to the Food and Drug Administration for use of CONCERTA(R) to treat adults with ADHD. CONCERTA(R) is already approved for the treatment of ADHD in children and adolescents ages six to 17.

About the Study

In the study presented today, efficacy was measured as a change in the Adult ADHD Investigator Symptom Rating Scale (AISRS) total score. The results showed that CONCERTA(R) achieved a significantly superior reduction in AISRS total score compared to placebo (p=0.012) (mean change was -10.6 +/-1.09 for the CONCERTA(R) group vs. -6.8 +/-1.06 for the placebo group.

In addition, CONCERTA(R) was significantly superior compared to placebo for the key secondary efficacy variables: change in Clinical Global Impression-Improvement (CGI-I) rating (p=0.008); change in Conners' Adult ADHD Rating Scale-Self Report (CAARS-S:S) total score (p=0.029) and change in percent of subjects m
'/>"/>

SOURCE McNeil Pediatrics
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ewswire/ -- nContact Surgical, Inc. ("nContact"), ...ally-invasive treatment for heart conditions, toda...al trial designed to evaluate the safety and effic... the convergent procedure, for the treatment of sy...is prospective, feasibility study will enroll pati...
(Date:12/1/2009)...ewswire/ -- Siemens Hearing Instruments, Inc., (...facturer of hearing instruments, announced its thi...ound Beginnings program. The alliance will be effe... renewed partnership, Siemens is expanding the pro...ruments to both children and young adults, age 23 ...
(Date:12/1/2009)...rstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE A...ompleted preclinical study has affirmed the bioequ...xotere® (docetaxel). Shin Poong Pharmaceutic..., independently conducted the study and data analy...bioequivalence and comparable overall safety of AN...
Breaking Medicine Technology:nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 3ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 2ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 3COSHAR Foundation Promotes Importance of Timely Childhood Immunization at Black Family Reunion Celebration in Washington D C 56444 1COSHAR Foundation Promotes Importance of Timely Childhood Immunization at Black Family Reunion Celebration in Washington D C 56444 2China Sky One Medical Inc Exports Pain Relief Patch to Canada 56442 1China Sky One Medical Inc Exports Pain Relief Patch to Canada 56442 2South Florida Technology Alliance and BioFlorida Joint Event Draws Big Names and Big Crowd 13908 1South Florida Technology Alliance and BioFlorida Joint Event Draws Big Names and Big Crowd 13908 2South Florida Technology Alliance and BioFlorida Joint Event Draws Big Names and Big Crowd 13908 3
...NTA, May 12 GeoVax Labs, Inc. (OTC,Bulletin Board...pment,company, announced today that it has entered...t with Fusion Capital Fund II, LLC, a Chicago-base...p to $10 million of its common stock to Fusion,Cap...r the Securities and,Exchange Commission has decla...
...ides the Optimal Combination of Scaffolding, Deliv...bility, TEL AVIV, Israel, May 12 Medinol is prou... Presillion(TM) CoCr Coronary Stent,enabling physi...nologically,innovative flexible closed cell design...folding the unprecedented,balance of flexibility a...
Other Medicine Technology:GeoVax Secures $10 Million Financing Commitment 2GeoVax Secures $10 Million Financing Commitment 3Medinol Receives CE Mark for Presillion(TM) Cobalt Chromium Coronary Stent on Rx System, an Advanced Evolution of the NIR(R) Family of Stents 2
(Date:12/1/2009)...ncerous lesions, researchers say , , TUE...trasound, elastography helps distinguish between c...unnecessary biopsies, U.S. researchers have found....biopsied turn out to be benign, according to the A...m to improve specificity with ultrasound, and elas...
(Date:12/1/2009)...e/ -- For many employers, the issue of quality and...ployee benefit, it,s providing for the needs of th...is leading this effort, with the help of Concentra... at its corporate offices, bringing quality and co...s and their dependents. ,, Beginning in Janu...
(Date:12/1/2009)...rages People to ,Fight AIDS. Love Life., ,,... on World AIDS Day, Gay Men,s Health Crisis (GMHC)... diverse groups disproportionately affected by HIV...l methamphetamine use. GMHC is announcing an inno...ce, www.MyMethLife.org , which aims to curb the r...
(Date:12/1/2009)...hers using functional MRI , , TUESDAY,...lead can cause permanent brain damage, a new study...gion of the brain is spared from lead exposure. Di...," study author Kim Cecil, an imaging scientist at... a professor of radiology, pediatrics and neurosci...
(Date:12/1/2009)...lucose intolerance (a condition less severe than g...ar risk factors as early as three months after bir...ion in The Endocrine Society,s Journal of Clinica...rchers in this study sought to evaluate the relati... postpartum risk of metabolic syndrome (defined as...
Breaking Medicine News(10 mins):Health News:Ultrasound With Elastography May Cut Down on Biopsies 2Health News:Hobby Lobby Selects Concentra to Open Health Center 2Health News:Hobby Lobby Selects Concentra to Open Health Center 3Health News:Nation's Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day 2Health News:Nation's Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day 3Health News:Childhood Lead Exposure Causes Permanent Damage: Study 2Health News:Glucose intolerance in pregnancy associated with postpartum cardiovascular risk 2
...ists Discuss the Latest Developments in Molecular,...l., Sept. 5 The practice of,pathology is at a tra...se,of personalized medicine will change the way pa...g a leadership role in,making sure that its member...
... Sept. 5 The Health Resources,and Services Admini...nts to,increase and improve medical services at th...e President Bush,s historic expansion of the,healt...izabeth M. Duke said. "In 2007, more than 16 milli...
...lain how theoretical ,anti-cloak, could bring obje...lthDay News) -- Just in case someone develops a cl...say they know how to uncloak the objects it hides....in. , Researchers at Shanghai Jiao Tong University...
...on John McCain to commit to develop a National AID..., Minn., Sep. 5 The,Republican National Conventio...stic AIDS epidemic in the United States and only p... in their remarks,to Convention delegates., The R...
...t. 5 Speaker Nancy Pelosi,issued the following st...,Up to Cancer" telethon, to be aired on all networ...y who has not seen a loved one,suffer because of c...icating the scourge of cancer a national priority ...
....Y., Sept. 5 Tonight is a momentous,occasion as t...industry,executives, celebrities and prominent lea...forces to Stand Up to Cancer. This collaboration,f...the discussion about cancer and the need to take a...
Other Medicine News:Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3Health News:The Leukemia & Lymphoma Society: Standing Up to Cancer for 60 Years 2
Carpentier-Edwards PERIMOUNT Magna Aortic Heart Valve
Dimension Vista System
...background in high performance ultrasound design p...iography. Echocardiography imaging requires superi...tive Doppler performance. The Terason Echo Ultraso...ech Architecture, delivers a compact imaging platf...
...background in high performance portable ultrasound... echocardiography. Echocardiography (ultrasound) ... frame rates, and sensitive Doppler performance. ...ason's proprietary Teratech Architecture, delivers...
Medicine Products: